What Researchers Did
Researchers treated a 15-year-old male with drug-resistant epilepsy using a combination of cell-based therapy derived from bone marrow, adipose tissue, and peripheral blood, along with hyperbaric oxygen therapy.
What They Found
After two sessions of cell-based therapy followed by neuro-physiotherapy and oxygen therapy, the patient experienced a decrease in seizure frequency and a reduction in anti-epileptic medication dosage. An electroencephalogram taken one year after the therapy revealed improvement in seizure activity.
What This Means for Canadian Patients
This case report offers a preliminary look at a potential new treatment strategy for drug-resistant epilepsy, a condition that can cause severe disability. If larger studies confirm these findings, Canadian patients with this challenging form of epilepsy might eventually have another treatment option to explore.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a single case report, these findings are preliminary and cannot be generalized to a wider patient population.